Updates to Medicare's Quality Payment Program That May Impact You.

Area of Science:

• Healthcare Policy
• Medical Economics

Background:

• The Merit-based Incentive Payment System (MIPS) is part of Medicare's Quality Payment Program.
• Pathologists face significant financial implications, with potential gains or losses of approximately $2 billion over 7 years.
• Compliance with MIPS is crucial for groups providing services to Medicare beneficiaries.

Purpose of the Study:

• To inform pathologists about the necessity of understanding MIPS requirements.
• To highlight the impact of MIPS on Medicare reimbursement.
• To guide pathologists in navigating and optimizing their participation in MIPS.

Main Methods:

• Analysis of Medicare's Quality Payment Program and MIPS regulations.
• Review of annual Final Rule updates from the Centers for Medicare & Medicaid Services.
• Examination of the reporting year structure and its impact on future reimbursements.

Main Results:

• The 2020 reporting year is the fourth for MIPS.
• Performance in 2020 directly influences 2022 Medicare Part B reimbursements, with potential adjustments of up to ±9%.
• Failure to comply can lead to reduced Medicare reimbursement.

Conclusions:

• Staying informed about evolving MIPS requirements is essential for pathologists.
• Understanding MIPS reporting differences across performance categories aids in maximizing scores.
• Successful MIPS compliance can reduce participation burden and optimize incentive potential.